Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
The Journal of Clinical and Aesthetic Dermatology|March 1, 2014
From the Test Tube to the Treatment Room: Fundamentals of Boron-containing Compounds and their Relevance to DermatologyJames Q Del Rosso, Jacob J PlattnerCurrent Opinion in Infectious Diseases|October 18, 2011
Boron-based drugs as antiprotozoalsRobert T Jacobs, Jacob J Plattner, Martine KeenanJournal of Molecular Biology|May 12, 2009
Crystal structures of the human and fungal cytosolic Leucyl-tRNA synthetase editing domains: A structural basis for the rational design of antifungal benzoxaborolesElena Seiradake, Weimin Mao, Vincent Hernandez, et al.Bioorganic & Medicinal Chemistry Letters|April 28, 2004
Novel lopinavir analogues incorporating heterocyclic replacements of six-member cyclic urea--synthesis and structure-activity relationshipsHing L Sham, David A Betebenner, William Rosenbrook, et al.Bioorganic & Medicinal Chemistry Letters|April 6, 2002
Synthesis and structure-activity relationships of a novel series of HIV-1 protease inhibitors encompassing ABT-378 (Lopinavir)Hing L Sham, David A Betebenner, Xiaoqi Chen, et al.Bioorganic & Medicinal Chemistry Letters|June 21, 2006
Synthesis and antibacterial activity of C12 des-methyl ketolidesXiaodong Lin, Alice C Rico, Daniel T Chu, et al.Bioorganic & Medicinal Chemistry Letters|October 10, 2002
Novel lopinavir analogues incorporating non-Aromatic P-1 side chains--synthesis and structure--activity relationshipsHing L Sham, Chen Zhao, Leping Li, et al.Bioorganic & Medicinal Chemistry Letters|March 24, 2009
Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitisTsutomu Akama, Stephen J Baker, Yong-Kang Zhang, et al.Bioorganic & Medicinal Chemistry|May 16, 2006
Synthesis and antibacterial activity of novel C12 ethyl ketolidesMatthew T Burger, Christy Hiebert, Mehran Seid, et al.Journal of Medicinal Chemistry|July 21, 2006
Discovery of a new boron-containing antifungal agent, 5-fluoro-1,3-dihydro-1-hydroxy-2,1- benzoxaborole (AN2690), for the potential treatment of onychomycosisStephen J Baker, Yong-Kang Zhang, Tsutomu Akama, et al.Pageof 6